WHO developing a guideline on the management of health complications related to Female Genital Mutilation
Your input is invited for a brief survey as part of the guideline development process of the first Guideline on the management of health complications related to Female Genital Mutilation (FGM) – currently being developed by WHO Department of Reproductive Health and Research (RHR) including HRP.
6 FEB 2015 – WORLDWIDE - WHO joins people across the globe today, to stand in solidarity against Female Genital Mutilation (FGM), and to highlight the crucial role that health-workers can play to help end this practice. Female Genital Mutilation is a global health issue, and can have devastating physical, psychological, and social consequences for women and girls.
New study highlights need for more research on female genital mutilation (FGM)
December 2014. A study, published in the International Journal of Obstetrics and Gynaecology (BJOG) calls for further evidence on how to improve the care of women living with female genital mutilation (FGM). Conducted by WHO and the Geneva University Hospital, this study highlights that more than 125 million girls and women have been subjected to FGM and at least three million girls remain at risk every year. This paper reviews the existing evidence on obstetric outcomes, surgical interventions, and skills and training of health care professionals involved in the prevention and management of FGM and identifies future priority research areas.